schizandrer a has been researched along with dinoprostone in 2 studies
| Studies (schizandrer a) | Trials (schizandrer a) | Recent Studies (post-2010) (schizandrer a) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 65 | 0 | 52 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | schizandrer a (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ci, X; Deng, X; Li, H; Li, R; Ren, R; Song, Y; Wang, D; Xu, K; Yu, Q | 1 |
| Jun, F; Li, D; Liao, S; Wang, J; Xie, X; Zhou, K | 1 |
2 other study(ies) available for schizandrer a and dinoprostone
| Article | Year |
|---|---|
Schisantherin A exhibits anti-inflammatory properties by down-regulating NF-kappaB and MAPK signaling pathways in lipopolysaccharide-treated RAW 264.7 cells.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cell Survival; Cyclooctanes; Cyclooxygenase 2; Dinoprostone; Dioxoles; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; I-kappa B Kinase; Inflammation Mediators; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lignans; Lipopolysaccharides; Macrophages; MAP Kinase Signaling System; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2010 |
Schisantherin A suppresses interleukin-1β-induced inflammation in human chondrocytes via inhibition of NF-κB and MAPKs activation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Chondrocytes; Cyclooctanes; Cyclooxygenase 2; Dinoprostone; Dioxoles; Enzyme Activation; Humans; Interleukin-1beta; Lignans; Matrix Metalloproteinases; Middle Aged; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Osteoarthritis; Tumor Necrosis Factor-alpha | 2016 |